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Abstract: The expression of major
histocompatibility antigens class II (MHC II) in
renal diseases has been studied extensively in
the tubulo-interstitial compartment, while
there are few articles about their expression
in the glomeruli. In this series, glomerular
expression of HLA DR DP DQ is evaluated in a
total of 62 cases of pyelonephritis,
glomerulonephritis, tubulointerstitial nephritis
and
systemic
diseases
with
renal
manifestations in order to identify their
relationship with disease status and renal
scarring.

Dokuz Eylül University Faculty of Medicine
1
2
Departments of Pathology , Nephrology ,
3
Pediatric Nephrology, Faculty of Medicine
Dokuz Eylül University, ‹zmir-TURKEY

Formaline fixed paraffin embedded tissue
sections from renal biopsy and nefrectomy
specimens were stained by an antibody
against HLA DR DP DQ by the streptavidin
biotin method. Autopsy kidneys were used as
control tissues. In order to understand the
significance of glomerular HLA DR DP DQ
expression in renal tissues, the results were
correlated with glomerular sclerosis,
interstitial fibrosis, tubular atrophy and
interstitial inflammation by Spearman and
Pearson correlation tests. Disease groups

Introduction
The major histocompatibility complex (MHC) is composed of three main HLA-class II loci, DR, DP and DQ.
Their expression was first observed in B lymphocytes, followed by endothelial cells, T-cells and also epithelial cells
in the tongue, tonsils, epiglottis, trachea, small intestine,
urethra, epididymis and proximal tubular cells (1,2).
The tubular expression of HLA class II molecules has
been extensively studied. It is known that HLA class II
expression is increased in renal tubular epithelial cells
both in renal allograft rejection and many forms of renal
disease (2-7). On the other hand, there are few articles
about the expression of HLA class II antigens in glomeruli
in renal diseases (3,6,8). HLA class II antigens are important in antigen presentation. The expression leads to

were compared with Kolmogorov-Smirnov
tests in independent samples.
Increased expression was identified in cases
with
chronic
pyelonephritis
and
membranoproliferative glomerulonephritis
compared with autopsy kidneys. On the other
hand, when all the cases were considered, no
correlation was found between glomerular
HLA expression and glomerular sclerosis
(p=0.458, r=-0.104), tubular atrophy
(p=0.9, r=0.018) interstitial fibrosis
(p=0.725, r=-0.049) and inflammation
(p=0.987, r= 0.002).
As there are few cases in each disease
category, it is hard to reach definite
conclusions about the different nature of HLA
class II antigen expression in renal diseases.
But their effect on renal scarring is not
indicated by this study.
Key Words: HLA DR DP DQ, renal diseases,
glomerular expression, immunohistochemistry,
renal scarring.

regional T-cell accumulation (9,10). T-lymphocytes play
an important role in fibroblast proliferation through the
secretion of growth factors like interleukin-4 (IL-4),
tumour necrosing factor-α (TNF-α) and transforming
growth factor-β (TGF-β) (11). TGF-β activates cell proliferation and migration of more T-cells (11,12). TGF-β is
a fibrogenic cytokine and induces ECM synthesis, particularly of type I and III collagens (13). Like tubular cells,
immune or non-immune injury to the glomerular cells
may lead to MHC class II antigen expression, which is recognized by T-lymphocytes, and the IFN-γ secreted by the
T-lymphocytes may increase MHC class II antigen expression (14,15).
The aim of the present study is to evaluate glomerular HLA DR DP DQ expression in autopsy kidneys and
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pyelonephritis, glomerulonephritis, tubulointerstitial diseases and systemic diseases with emphasis on parameters
of renal scarring such as glomerular, tubular and interstitial scarring, in order to highlight the role of this altered
expression on renal scarring.

Materials and Methods
Five autopsy kidney specimens with normal renal
morphology, 6 nephrectomy specimens with chronic
pyelonephritis and 56 renal kidney needle biopsy specimens were evaluated for glomerular MHC class II expression and the results were correlated with interstitial
inflammation, tubular atrophy, interstitial fibrosis and
percentage of sclerotic glomeruli as well as primary diagnosis of the renal disease. Renal biopsy specimens have
previously been evaluated by light microscopy and direct
immunofluorescence (DIF). The distribution of the renal
biopsies were as follows: IgA nephropathy (7 cases),
membranoproliferative glomerulonephritis (MPGN) (11
cases),
mesangioproliferative
glomerulonephritis
(MesGN) (3 cases), postinfectious glomerulonephritis
(PIGN) (4 cases), crescentic glomerulonephritis (CrGN) (2
cases), minimal change disease (MCD) (2 cases), membranous glomerulonephritis (MGN) (14 cases), interstitial
nephritis (IN) (3 cases), systemic lupus erythematosus
(SLE) (4 cases), diabetic nephropathy (DN) (5 cases),
chronic pyelonephritis (PN) (6 cases) and diffuse
glomerulosclerosis (1 case).

St. Louis, USA) was used as the chromogen. Sections
were counterstained by Mayer’s haematoxylin, and dehydrated in an increasing alcohol series.
Semi-quantitative evaluation
Immunohistochemical reaction intensity was evaluated
in sections where at least 5 glomeruli could be observed.
As endothelial cell staining with HLA class II antibodies is
a constant finding observed in this study as well as in others, only glomerular mesangial and epithelial cells in the
mesangial area were evaluated. Cytoplasmic and cell
membrane staining was positive. Semiquantitative scores
were given for glomerular HLA DR DP DQ expression as
described before (3): No staining (0), a single positive cell
(1), a few positive cells, expression by more than 10%
and less than 50% of cells/glomeruli (2), many positive
cells, more than 50% of cells/glomerulae (3) (Figure).

Immunohistochemistry
The peroxidase labelled streptavidine biotine method
(by Large volume DAKO LSAB II kit, peroxidase, DAKO
Corp, Carpinteria, USA) was used along with the primary
antibody against HLA DR DP DQ antigens (dil:1/50, DAKO
Corp, Carpinteria, USA) for immunohistochemical staining. Tissue sections from formaline fixed paraffin embedded tissue blocks were taken on poly-l-lysine coated
slides. Deparaffinisation was followed by rehydration in
an alcohol series from 96% to 70%. Phosphate buffered
saline solution (PBS) wash was performed for five minutes and it was repeated after every step. Endogenous
peroxidase activity was blocked by 3% hydrogen peroxide. Sections were boiled in PBS twice for 5 minutes in a
microwave oven. Primary antibody was applied for 30
minutes. Biotinylated secondary antibody and streptavidin
peroxidase solutions were applied for 10 minutes following PBS washes. Diaminobenzidine (Sigma Chemical Co,
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Figure 1.

Glomerular HLA DR DP DQ expression in crescentic
glomerulonephritis which was scored as 2 considering the
group of mesangial cells with positive staining, while many
cells at the other mesangial regions are negative. Note the
few positive cells at the proliferative lesion at the Bowman’s
capsule, as well as tubular strong expression (DAB,
IHCx200).

Morphometric evaluation of interstitial fibrosis
The point counting method was used for the determination of interstitial fibrosis in Masson’s Trichrome
stained sections as described by Howie et al. (16). Cortical areas adjacent to glomeruli were selected and
observed at high power magnification. The images were
obtained on a monitor (Sony) by a video camera (Sony) at
2100x magnification. A grid with 11 horizontal and vertical lines producing 121 intersecting points was put on
the monitor. The points of intersection, which were
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imposed on a green stained interstitium, were counted in
10 different areas by high power magnification. Points
falling on other fields were also counted in the same
areas, but glomeruli and vascular structures were excluded. The final result was found as follows:
number of points falling on interstitum
Interstitial fibrosis =
number of points falling on cortical tissue
(excluding glomeruli and vascular structures)

Quantification of sclerotic glomeruli
The proportion of sclerotic glomeruli to the number
of all glomeruli in the tissue section was considered the
glomerulosclerosis ratio.
Semiquantitative scoring of tubular atrophy and
interstitial inflammation
Tubular atrophy was scored in periodic acid Schiff
(PAS) stained sections while interstitial inflammation was
scored in H&E stained sections by a modified scoring system adapted from Lajoe and Silva (17) as follows:
Scoring of tubular atrophy: 0: No atrophic changes; 1:
atrophic changes in 20% of tubules; 2: atrophic changes
in 20-40% of tubules; 3: atrophic changes in 40-70% of
tubules; 4: atrophic changes in more than 70% of
tubules.
Scoring of interstitial inflammation: 0: No inflammation; scores of 1, 2, 3 and 4 were given for cases with
interstitial inflammation in 20%, 20-40%, 40-70% and
70-100% of the cortical interstitial area respectively.

Table.

Statistical Analysis
Statistical analysis was performed with Scientific
Package for Social Sciences (SPSS) for Windows.
Glomerular HLA DR DP DQ expression scores were correlated with morphometric interstitial fibrosis values,
sclerotic glomeruli percentage, tubular atrophy and interstitial inflammation scores by Spearman correlation tests.
All groups of cases with different histopathological diagnosis were compared with each other for HLA DR DP DQ
expression by Kolmogorov-Smirnov tests in independent
samples. Results with p*0.05 or p=0.05 were considered
statistically significant.

Results
The glomerular HLA DR DP DQ antigen expression
scores for the disease groups were as follows: IgA nephritis: 0-3 (mean 1.45); MPGN: 1-2 (mean 1.36); MesGN:
0-3 (mean 2.9); PIGN: 1-2 (mean 1.5); CrGN:1-2 (mean
1.5); MCD: 0-1 (mean 0.5); MGN: 0-2(mean 0.35); IN:
0-1 (mean: 0.33); SLE nephritis: 0-3 (mean:2); DN: 0-1
(mean: 0.8); chronic pyelonephritis: 0-2 (mean:1.5); and
diffuse glomerulosclerosis: 1. The results for autopsy kidneys ranged from 0 to 1 (mean: 0.4) (Table).
The results of Kolmogorov-Smirnov Tests in independent samples comparing glomerular HLA scores in different disease groups were not statistically significant
(p*0.05), but glomerular HLA scores were higher in cases
of MPGN (p=0.003) and CP (p=0.044) than in autopsy
kidneys.

HLA DR DP DQ expression scores for renal diseases. Diffuse glomerulosclerosis with expression of HLA score: 1 is not shown in this table.
(IgA: IgA nephritis, MPGN: memranoproliferative glomerulonephritis, Mes GN: mesangial proliferative glomerulonephritis, PIGN: postinfectious glomerulonephritis, CrGN: crescentic glomerulonephritis, MCD: minimal change disease, MGN: membranous glomerulonephritis, IN:
interstitial nephritis, SLE: systemic lupus erythematosus associated nephritis, DN: diabetic nephropathy, CPn: chronic pyelonephritis, AU:
autopsy kidneys.)

HLA
Score

IgA

MP
GN

Mes
GN

PI
GN

Cr
GN

MCD

MGN

IN

SLE

DN

CPn

AU

0
1
2
3

3
2
2

7
4
-

1
2

2
2
-

1
1
-

1
1
-

10
3
1
-

2
1
-

1
2
1

1
3
1
-

1
4
1
-

4
1
-

total

7

11

3

4

2

2

14

3

4

5

6

5
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When all the cases were considered, no correlation
was found between glomerular HLA expression and
glomerular sclerosis (p=0.458, r=-.0.104), tubular atrophy (p=0.9, r=0.018) interstitial fibrosis (p=0.725, r=0.049) and inflammation (p=0.987, r= 0.002).

neys. On the other hand, by statistical analysis no correlation was found between interstitial inflammation and
glomerular HLA class II antigen expression when all the
cases were considered. But in this series, an antibody
against HLA DR DP DQ antigens was used, which may be
the reason for the controversial results.

Discussion

In this study, statistical analysis comparing each disease group with the others and with autopsy kidneys was
carried out. Except for the increased expression observed
in MPGN and CP, none of the diseases were different
from the others. These results may be affected by the low
number of cases found in the disease groups and to the
different stages of disease at the time of biopsy.

There are controversial results about the distribution
of glomerular MHC class II antigens in both normal and
pathological renal tissues. The different antibodies used in
different series rather complicate the issue. Daar et al. (1)
noted MHC class II antigen expression constantly in
glomerular mesangial and endothelial cells by NFK1 antibody in normal tissues. Müller et al. (3) used 4 primary
antibodies against MHC class II antigens (TÜ22+DQ,
TÜ34+DR, B7/21+DP, TÜ39+DR/DP/DY) and found
TÜ39+DR/DP/DY expression in many glomerular cells
and fewer cells with the other antibodies. They noted
reduced HLA DR DP DY antigen expression in RPGN and
reduced HLA DP and/or DR + cells in MesGN and MPGN
although statistical analysis was not performed. In contrast with these results, in this series, MPGN cases were
found to express increased HLA class II antigens, compared with autopsy kidneys. Although the antibody used
in this study is not identical with the previous one, we
think that reduced expression of HLA antigens in MPGN
is a rather unexpected finding as mesangial proliferation
and mesangial matrix expansion is a common feature for
this disease group.
Wadgmayer et al. (6) stained normal renal biopsy
specimens by anti HLA-DR antibody and stated that
podocytes, mesangial cells and Bowman’s capsule cells of
normal glomeruli stained negative by HLA-DR antibody.
They found increased glomerular HLA-DR antibody
expression in cases with severe interstitial inflammation,
as in transplant rejection, interstitial nephritis and lupus
nephritis with extensive interstitial infiltrates. In this
series 6 cases of CP were evaluated with rich interstitial
infiltrates. Consistent with the findings of Wadgmayer et
al. (6), in these cases increased HLA DR DP DQ antigen
expression was observed, as compared to autopsy kid-

It is known that epithelial cells expressing MHC class
II determinants can present antigens to cloned T cells.
This is a very important step in the induction of both
humoral and cellular immune responses (18). Li et al.
(19) suggested that interaction of CD4 (+) T cell infiltration and intrinsic renal cells expressing MHC II is required
for cell-mediated immune renal injury. This brings up the
possibility of increased injury at sites with increased HLA
class II antigen expression. If this is a major mechanism in
renal scarring during renal diseases, one should expect an
increased GS ratio for cases with increased HLA DR DP
DQ expression. Also, interstitial fibrosis and tubular atrophy are frequently correlated with GS. Thus, on the
whole, atrophic changes in three compartments should be
expected. The attempt to find any correlation with
glomerular HLA DR DP DQ expression scores and sclerotic glomeruli ratio, tubular atrophy and interstitial fibrosis
failed in this series. These findings argue against the value
of glomerular HLA DR DP DQ expression in progressing
renal disease. Still, as the series includes many different
diseases, it is hard to reach a definite conclusion when
separate entities are considered.
Correspondence author:
Sülen SARIO⁄LU
Dokuz Eylül University School of Medicine,
Department of Pathology
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